In vivo receptor binding, neurochemical and functional studies with the dopamine D-1 receptor antagonist SCH 23390

1988 ◽  
Vol 72 (2) ◽  
pp. 83-97 ◽  
Author(s):  
S. Hjorth ◽  
A. Carlsson
Keyword(s):  
Receptor Antagonist ◽  
Receptor Binding ◽  
Sch 23390 ◽  
Functional Studies ◽  
In Vivo Receptor Binding

In vitro and in vivo receptor binding and deoxyglucose studies in rat brain with the potential antipsychotic Org 5222

1990 ◽  
Vol 183 (5) ◽  
pp. 1623
Author(s):  
J.A.D.M. Tonnaer ◽  
P. Room ◽  
W.M.J.B. Van Gemert ◽  
L.P.C. Delbressine ◽  
T. de Boer ◽  
...  
Keyword(s):  
Rat Brain ◽  
Receptor Binding ◽  
In Vivo Receptor Binding

Modulation of voltage-dependent K+ currents (IK(V)) in retinal bipolar cells by ascorbate is mediated by dopamine D1 receptors

1999 ◽  
Vol 16 (5) ◽  
pp. 923-931 ◽  
Author(s):  
SHIH-FANG FAN ◽  
STEPHEN YAZULLA
Keyword(s):  
Receptor Antagonist ◽  
Glutamate Uptake ◽  
Sch 23390 ◽  
D2 Receptor ◽  
Bipolar Cells ◽  
D1 Receptors ◽  
Voltage Dependent ◽  
Average Latency

Ascorbic acid (AA), a neuromodulator in the vertebrate CNS, is released from glutamatergic neurons in exchange with glutamate uptake and, in turn, modulates the release of both glutamate and dopamine. We have reported that voltage-gated K+ currents (IK(V)) in ON-mixed rod/cone bipolar cells (Mb) were suppressed 60% by 100–200 μM AA when added to an ascorbate-free solution. However, as the in vivo [AA]o in retina is about 200 μM, we studied the effects of changes in [AA]o on IK(V) when [AA]o was varied around a baseline concentration of 200 μM. Whole-cell currents were recorded with patch-clamp methods from goldfish Mb cells in retinal slices, bathed in a solution containing 200 μM AA. We found that (1) IK(V) was enhanced (180 ± 36%, n = 9) by increases of [AA]o less than 40 μM with an average latency of 8 min. (2) However, IK(V) was suppressed without an appreciable latent period by two conditions: increases more than 40 μM [AA]o and decreases by any amount greater than 10 μM. (3) Effects of Δ[AA]o on IK(V) were blocked by a D1 dopamine receptor antagonist, SCH 23390, but not by a D2 receptor antagonist, spiperone. Increased concentrations of a D1 agonist (SKF 38390) and dopamine had similar concentration-dependent effects on IK(V) as did AA, even in the presence of 200 μM ascorbate. Ascorbate has complicated concentration-dependent effects on IK(V) of Mb cells in vitro that were mediated by D1 dopamine receptors, suggesting that dopamine and ascorbate may be involved reciprocally in modulating IK(V), with consequences on the transmission of rod signals to the inner retina.

scholarly journals In vitro and in vivo receptor binding profile of NRA0161 and NRA0562, novel atypical antipsychotics

1999 ◽  
Vol 79 ◽  
pp. 236
Author(s):  
Takeo Funakoshi ◽  
Shigeyuki Chaki ◽  
Ryoko Yoshikakwa ◽  
Shigeru Okuyama ◽  
Atsuro Nakazato ◽  
...  
Keyword(s):  
Receptor Binding ◽  
Atypical Antipsychotics ◽  
Binding Profile ◽  
In Vivo Receptor Binding

Characterization of the radioiodinated analogue of SCH 23390: In vitro and in vivo D-1 dopamine receptor binding studies

Life Sciences ◽  
1988 ◽  
Vol 43 (14) ◽  
pp. 1151-1160 ◽  
Author(s):  
Robert D. McQuade ◽  
Richard Chipkin ◽  
Nordine Amlaiky ◽  
Marc Caron ◽  
Louis Iorio ◽  
...  
Keyword(s):  
Dopamine Receptor ◽  
Receptor Binding ◽  
Sch 23390 ◽  
Binding Studies ◽  
Dopamine Receptor Binding
Sign in / Sign up

Export Citation Format

Share Document